Research & development decreased 23.0%
Research & development changed -23.0% from the comparable as-filed period.
$2.2M→$1.7M0 prior comparisons
GROSSPATTERN / DETERMINISTIC EVIDENCE / V3
Search securities →CXAI financial changes
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Total assets increased 23.6%
Total assets changed +23.6% from the comparable as-filed period.
$29.6M→$36.5M3 prior comparisons
Current ratio increased 101.4%
Current ratio changed +101.4% from the comparable as-filed period.
0.82→1.643 prior comparisons
Working capital / assets moved 1918 bp higher
Working capital / assets changed +1918 basis points from the comparable as-filed period.
-4.79%→14.39%3 prior comparisons
Operating cash-flow margin moved 11375 bp higher
Operating cash-flow margin changed +11375 basis points from the comparable as-filed period.
-246.28%→-132.53%0 prior comparisons
R&D / revenue moved 7967 bp lower
R&D / revenue changed -7967 basis points from the comparable as-filed period.
179.31%→99.65%0 prior comparisons
Receivables / revenue moved 2521 bp lower
Receivables / revenue changed -2521 basis points from the comparable as-filed period.
66.88%→41.68%0 prior comparisons
Working capital changed across a sign change
Working capital changed +471.6% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a sign change.
-$1.4M→$5.3M3 prior comparisons
Trade receivables decreased 13.7%
Trade receivables changed -13.7% from the comparable as-filed period.
$818,000→$706,0001 prior comparisons
Current liabilities increased 7.1%
Current liabilities changed +7.1% from the comparable as-filed period.
$7.7M→$8.2M3 prior comparisons
Operating income decreased 0.2%
Operating income changed -0.2% from the comparable as-filed period.
-$4.1M→-$4.1M0 prior comparisons
Gross profit increased 1.8%
Gross profit changed +1.8% from the comparable as-filed period.
$1.1M→$1.1M1 prior comparisons
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.